Control of the rat angiotensin I converting enzyme gene by CRE-like sequences

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 10, 2004, Pages 1441-1453

  Xavier Neto, J ^a   Pereira, A C ^a   Oliveira, E M ^a   Miyakawa, A A ^a   Junqueira, M L ^a   Krieger, J E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin converting enzyme; cAMP; Cyclic AMP responsive element; Endothelium

Indexed keywords

8 BROMO CYCLIC AMP; ACTIVATING TRANSCRIPTION FACTOR 2; DIPEPTIDYL CARBOXYPEPTIDASE; PROTEIN C JUN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; ENDOTHELIUM CELL; ENHANCER REGION; GENE ACTIVATION; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC SCREENING; GENETIC TRANSFECTION; HUMAN; KIDNEY CELL; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; RABBIT; RAT; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; STRESS; TRANSCRIPTION INITIATION SITE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 5644269197     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004001000002     Document Type: Article

References (32)

1. Friedland J, Setton C & Silverstein E (1977). Angiotensin converting enzyme: induction by steroids in rabbit alveolar macrophages in culture. Science, 197: 64-65.
2. Krulewitz AH, Baur WE & Fanburg BL (1984). Hormonal influence on endothelial cell angiotensin-converting enzyme activity. American Journal of Physiology, 247: C163-C168.
3. Dasarathy Y, Lanzillo JJ & Fanburg BL (1982). Stimulation of bovine pulmonary artery endothelial cell ACE by dexamethasone: involvement of steroid receptors. American Journal of Physiology, 263: H645-H649.
4. Dasarathy Y & Fanburg BL (1989). Calcium ionophore A23187 elevates angiotensin-converting enzyme in cultured bovine endothelial cells. Biochimica et Biophysica Acta, 1010: 16-19.
5. Fishel RS, Thourani V, Eisenberg SJ, Shai SY, Corson MA, Nabel EG, Bernstein KE & Berk BC (1995). Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury. Journal of Clinical Investigation, 95: 377-387.
6. Kyriakis JM & Avruch J (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiological Reviews, 81: 807-869.
7. Weinstock JV (1986). The significance of angiotensin I converting enzyme in granulomatous inflammation. Functions of ACE in granulomas. Sarcoidosis, 3: 19-26.
8. Lloyd CJ, Cary DA & Mendelsohn FAO (1987). Angiotensin converting enzyme induction by cyclic AMP and analogues in cultured endothelial cells. Molecular and Cellular Endocrinology, 52: 219-225.
9. Dasarathy Y & Fanburg BL (1988). Elevation of angiotensin converting enzyme by 3-isobutyl-1-methylxanthine in cultured endothelial cells: a possible role for calmodulin. Journal of Cellular Physiology 137: 179-184.
10. Xavier-Neto J, Pereira AC, Junqueira ML, Carmona R & Krieger JE (1999). Rat angiotensin-converting enzyme promoter regulation by beta-adrenergics and cAMP in endothelium. Hypertension, 34: 31-38.
11. Montminy MR (2001). Transcriptional regulation by the phosphorylation-dependent factor CREB. Nature Reviews. Molecular Cell Biology, 2: 599-609.
12. Roesler WJ (2000). What is a cAMP response unit? Molecular and Cellular Endocrinology, 162: 1-7.
13. Gao B, Chen J, Johnson C & Kunos G (1997). Both the cyclic AMP response element and the activator protein 2 binding site mediate basal and cyclic AMP-induced transcription from the dominant promoter of the rat alpha 1B-adrenergic receptor gene in DDT1MF-2 cells. Molecular Pharmacology, 52: 1019-1026.
14. Xavier-Neto J, Pereira AC, Motoyama AH & Krieger JE (1998). A luciferase-engineered cell line for study of cAMP regulation in endothelial cells. American Journal of Physiology, 275: C75-C81.
15. Matsuda S, Maekawa T & Ishii S (1991). Identification of the functional domains of the transcriptional regulator CRE-BP1. Journal of Biological Chemistry, 266: 18188-18193.
16. Williams T & Tjian R (1991). Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes and Development, 5: 670-682.
17. Doucas V, Spyrou G & Yaniv M (1991). Unregulated expression of c-Jun or c-Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cells. EMBO Journal, 10: 2237-2245.
18. Buonassisi V & Venter JC (1976). Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proceedings of the National Academy of Sciences, USA, 73: 1612-1616.
19. Graham FL & van der Eb AJ (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology, 52: 456-459.
20. Ribeiro PC, Apriletti JW, Yen PM, Chin WW & Baxter JD (1945). Heterodimerization and deoxyribonucleic acid-binding properties of a retinoid X receptor-related factor. Endocrinology, 135: 2076-2085.
21. Krieger JE, Junqueira ML & Dzau VJ (1994). Characterization of the promoter from rat angiotensin-converting enzyme gene. Circulation, 90: 130 (Abstract).
22. Johnson GL & Lapadat R (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912.
23. Gustin K & Burk RD (2000). PCR-directed linker scanning mutagenesis. Methods in Molecular Biology, 130: 85-90.
24. Fisch TM, Prywes R, Simon MC & Roeder RG (1989). Multiple sequence elements in the c-fos promoter mediate induction by cAMP. Genes and Development, 3: 198-211.
25. Soubt MK, Marksitzer R, Menoud PA & Nagamine Y (1998). Role of tissue-specific transcription factor LFB3 in a cyclic AMP-responsive enhancer of the urokinase-type plasminogen activator gene in LLC-PK1 cells. Molecular and Cellular Biology, 18: 4698-4706.
26. Jungmann RA, Huang D & Tian D (1998). Regulation of LDH-A gene expression by transcriptional and posttranscriptional signal transduction mechanisms. Journal of Experimental Zoology, 282: 188-195.
27. Murasawa S, Matsubara H, Kijima K, Maruyama K, Ohkubo N, Mori Y, Iwasaka T & Inada M (1996). Down-regulation by cAMP of angiotensin II type 2 receptor gene expression in PC12 cells. Hypertension Research 19: 271-279.
28. Giono LE, Varone CL & Canepa ET (2001). 5-Aminolaevulinate synthase gene promoter contains two cAMP-response element (CRE)-like sites that confer positive and negative responsiveness to CRE-binding protein (CREB). Biochemical Journal, 353: 307-316.
29. Vuillaumier S, Dixmeras I, Messai H, Lapoumeroulie C, Lallemand D, Gelkas J, Chehab FF, Perret C, Elion J & Denamur E (1997). Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation. Biochemical Journal, 327: 651-662.
30. Esther Jr CR, Semeniuk D, Marino EM, Zhou Y, Overbeek PA & Bernstein KE (1997). Expression of testis angiotensin-converting enzyme is mediated by a cyclic AMP responsive element. Laboratory Investigation, 77: 483-488.
31. Kessler SP, Rowe TM, Blendy JA, Erickson RP & Sen GC (1998). A cyclic AMP response element in the angiotensin-converting enzyme gene and the transcription factor CREM are required for transcription of the mRNA for the testicular isozyme. Journal of Biological Chemistry, 273: 9971-9975.
32. Hancock JM, Shaw PJ, Bonneton F & Dover GA (1999). High sequence turnover in the regulatory regions of the developmental gene hunchback in insects. Molecular Biology and Evolution, 16: 253-265.